STAGE IA BREAST CANCER AJCC V7
Clinical trials for STAGE IA BREAST CANCER AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE IA BREAST CANCER AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE IA BREAST CANCER AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for tough breast cancer: drug cocktail targets resistant tumors
Disease control CompletedThis phase II trial tested a combination of panitumumab (a targeted therapy) plus two chemotherapy drugs (carboplatin and paclitaxel) given before surgery to women with triple-negative breast cancer that didn't respond to standard chemo. The goal was to shrink tumors and reduce t…
Matched conditions: STAGE IA BREAST CANCER AJCC V7
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 23, 2026 12:09 UTC
-
Promising combo may keep breast cancer from returning
Disease control CompletedThis study tested a combination of two chemotherapy drugs (cyclophosphamide and paclitaxel) plus a targeted antibody (trastuzumab) given after surgery to 20 patients with early-stage HER2-positive breast cancer. The goal was to see if this treatment is safe and can prevent the ca…
Matched conditions: STAGE IA BREAST CANCER AJCC V7
Phase: PHASE2 • Sponsor: University of Nebraska • Aim: Disease control
Last updated Jun 22, 2026 11:59 UTC
-
Smart pill bottles and video visits boost cancer drug adherence
Disease control CompletedThis study tested whether using telehealth (video visits with a doctor) and smart pill bottles can help breast cancer patients take their hormone therapy more consistently. 305 women and men with early-stage hormone receptor-positive breast cancer participated. The goal was to se…
Matched conditions: STAGE IA BREAST CANCER AJCC V7
Phase: NA • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Jun 22, 2026 11:56 UTC
-
New combo shrinks hard-to-treat breast tumors before surgery
Disease control CompletedThis study tested a combination of enzalutamide (a hormone blocker) and paclitaxel (chemotherapy) given before surgery to 24 people with a specific type of triple-negative breast cancer that has androgen receptors. The goal was to see if this treatment could shrink tumors enough …
Matched conditions: STAGE IA BREAST CANCER AJCC V7
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 09, 2026 12:08 UTC